| VEEV Stock | | | USD 216.58 2.04 0.95% |
Director
Mr. Timothy C. Barabe is Independent Director of Veeva Systems Inc. Mr. Barabe has served as a member of our Board since September 2015. He retired in 2013 as Executive Vice President and Chief Financial Officer of Affymetrix, Inc. Previously, from July 2006 until March 2010, he was Senior Vice President and Chief Financial Officer of Human Genome Sciences, Inc. Mr. Barabe served as Chief Financial Officer of Regent Medical Limited, a U.K.based, privately owned, surgical supply company, from 2004 to 2006. He was with Novartis AG from 1982 through August 2004, where he served in a succession of senior executive positions in finance and general management, most recently as the Chief Financial Officer of Sandoz GmbH, the generic pharmaceutical subsidiary of Novartis. Mr. Barabe serves on the board of directors of ArQule, Inc. and Selecta Biosciences, Inc. and served on the board of directors of Opexa Therapeutics from March 2014 to September 2017. Mr. Barabe also serves on the board of directors of Vigilant Biosciences, a private medical device company, and Project Open Hand, a nonprofit organization. He received his Bachelor of Business Administration degree in Finance from the University of Massachusetts and his MBA from the University of Chicago since 2015.
| Age | 67 |
| Tenure | 9 years |
| Address | 4280 Hacienda Drive, Pleasanton, CA, United States, 94588 |
| Phone | 925 452 6500 |
| Web | https://www.veeva.com |
Barabe currently serves on our Audit Committee and chairs our Nominating and Governance Committee.
Veeva Systems Management Efficiency
The company has return on total asset
(ROA) of
0.0639 % which means that it generated a profit of $0.0639 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
0.1318 %, meaning that it created $0.1318 on every $100 dollars invested by stockholders. Veeva Systems' management efficiency ratios could be used to measure how well Veeva Systems manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Veeva Systems'
Return On Assets are fairly stable compared to the past year.
Return On Equity is likely to climb to 0.20 in 2024, whereas
Return On Tangible Assets are likely to drop 0.1 in 2024. At this time, Veeva Systems'
Asset Turnover is fairly stable compared to the past year.
Veeva Systems Class currently holds 55.77
M in liabilities with Debt to Equity
(D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. Veeva Systems Class has a current ratio of 4.12, suggesting that it is
liquid enough and is able to pay its financial obligations when due. Note, when we think about Veeva Systems' use of debt, we should always consider it together with its cash and equity.
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California. Veeva Systems operates under Health Information Services classification in the United States and is traded on New York Stock Exchange. It employs 5482 people. Veeva Systems Class (VEEV) is traded on New York Stock Exchange in USA. It is located in 4280 Hacienda Drive, Pleasanton, CA, United States, 94588 and employs 7,172 people. Veeva Systems is listed under Health Care Technology category by Fama And French industry classification.
Management Performance
Veeva Systems Class Leadership Team
Elected by the shareholders, the Veeva Systems' board of directors comprises two types of representatives: Veeva Systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Veeva. The board's role is to monitor Veeva Systems' management team and ensure that shareholders' interests are well served. Veeva Systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Veeva Systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jonathan JD, General VP | |
| Ato Garrett, Director Relations | |
| Paul Sekhri, Independent Director | |
| Matthew Wallach, Co-Founder and Pres | |
| Timothy Barabe, Independent Director | |
| Alan Mateo, Executive Vice President of Global Sales | |
| Pinal Patel, Chief Officer | |
| Eleni Zuppas, President Staff | |
| Kristine Diamond, Principal Officer | |
| Jonathan Faddis, Senior Vice President, General Counsel, Corporate Secretary | |
| Jacques Mourrain, Regulatory Quality | |
| Vivian Welsh, Chief Officer | |
| Timothy Cabral, Interim Director | |
| Ronald Codd, Independent Director | |
| Matthew Robinson, Chief Officer | |
| Peter Gassner, Chief Executive Officer, Director | |
| Michele OConnor, Principal Accounting Officer | |
| Frederic Lequient, Senior Vice President - Global Customer Services | |
| Tina Hunt, Director | |
| Paul Chamberlain, Independent Director | |
| Brian Wagener, Chief Officer | |
| Mark Carges, Independent Director | |
| Gordon Ritter, Independent Chairman of the Board | |
| Priscilla Hung, Director | |
| Gunnar Hansen, Director Relations | |
| Mary Hedley, Independent Director | |
| E Zuppas, Chief Marketing Officer | |
| Brent Bowman, Chief Financial Officer | |
| Thomas Schwenger, President, Chief Operating Officer | |
| Marshall Mohr, Director | |
Veeva Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Veeva Systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Veeva Stock Analysis
When running Veeva Systems' price analysis, check to
measure Veeva Systems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veeva Systems is operating at the current time. Most of Veeva Systems' value examination focuses on studying past and present price action to
predict the probability of Veeva Systems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veeva Systems' price. Additionally, you may evaluate how the addition of Veeva Systems to your portfolios can decrease your overall portfolio volatility.